Dr Xinyu Daniel Li, MD, PHD | |
1323 Bia Route 4, Fort Thompson, SD 57339-0200 | |
(605) 245-1500 | |
Not Available |
Full Name | Dr Xinyu Daniel Li |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 1323 Bia Route 4, Fort Thompson, South Dakota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144421504 | NPI | - | NPPES |
5549010 | Medicaid | SD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 064592 (Georgia) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | TRN 10258 (Florida) | Secondary |
Entity Name | Fort Thompson Indian Health Service |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710995907 PECOS PAC ID: 9739080896 Enrollment ID: O20040120000889 |
News Archive
Palatin Technologies, Inc. today announced results of preclinical studies in respiratory tissue with PL-3994. In rat, guinea pig and human tissues, PL-3994 produced potent relaxation of isolated airway smooth muscle, indicating that PL-3994 may be a potent bronchodilator in humans.
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Southern Home Medical Equipment, Inc., a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, has selected Scott & Company, a Public Company Accounting Oversight Board approved accounting firm in Columbia, SC, to audit the Company's financials for the past two years and provide additional accounting services to the Company.
NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.
[A]s a political matter, an outright repeal isn't really a winner. Most Americans dislike the law, but few are gunning to do away with it altogether. They don't like its mandates and costs, but they'd prefer to see a scaled down law that still provides more access to health care. Republicans run the risk of overreaching on this, as Democrats did in pushing a vast expansion of government into the health care field.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Xinyu Daniel Li, MD, PHD Po Box 200, Fort Thompson, SD 57339-0200 Ph: () - | Dr Xinyu Daniel Li, MD, PHD 1323 Bia Route 4, Fort Thompson, SD 57339-0200 Ph: (605) 245-1500 |
News Archive
Palatin Technologies, Inc. today announced results of preclinical studies in respiratory tissue with PL-3994. In rat, guinea pig and human tissues, PL-3994 produced potent relaxation of isolated airway smooth muscle, indicating that PL-3994 may be a potent bronchodilator in humans.
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Southern Home Medical Equipment, Inc., a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, has selected Scott & Company, a Public Company Accounting Oversight Board approved accounting firm in Columbia, SC, to audit the Company's financials for the past two years and provide additional accounting services to the Company.
NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.
[A]s a political matter, an outright repeal isn't really a winner. Most Americans dislike the law, but few are gunning to do away with it altogether. They don't like its mandates and costs, but they'd prefer to see a scaled down law that still provides more access to health care. Republicans run the risk of overreaching on this, as Democrats did in pushing a vast expansion of government into the health care field.
› Verified 7 days ago